Market growth is largely driven by factors such as increasing number of minimally invasive surgical procedures across the globe and the advantages of minimally invasive surgeries over traditional open surgeries. However, the uncertain regulatory framework in the medical device industry is a major factor restraining the growth of this market during the forecast period.
According to the new market research report Minimally Invasive Surgical Instruments Market is projected to reach $32.7 billion by 2025, at a CAGR of 8.5%.
The cardiothoracic surgery segment accounted for the largest share of the MIS instruments market in 2018. The large share of this segment can be attributed to the rising prevalence of cardiac diseases, the growing number of coronary and percutaneous cardiology interventions, growing awareness about the benefits of early detection of cardiovascular complications, and increasing adoption of MIS instruments owing to their convenience and better results as compared to other techniques.
The major players operating in the MIS instruments market are Medtronic plc (Ireland), Stryker Corporation (US), Johnson & Johnson (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682